Telesis Bio
Telesis Bio is dedicated to accelerating therapeutic discovery and synthetic biology workflows through advanced, rapid, and flexible automated DNA and RNA workflows. Their mission is to enable researchers to build biology efficiently, supporting the development of vaccines, therapeutics, diagnostics, and other applications. They develop innovative platforms such as the BioXp® system and Gibson SOLA platform, which automate gene synthesis, cloning, and assembly processes, significantly reducing development timelines and increasing productivity. Telesis Bio also envisions a future with a global network of vaccine printers and digital-to-biological converters to enable on-demand vaccine production and rapid response to pandemics.
Industries
Nr. of Employees
medium (51-250)
Patents
Materials and methods for the synthesis of error-minimized nucleic acid molecules
US-11884916-B2
View DetailsMethods of cloning nucleic acids or producing proteins in a low endotoxin organism
US-11746321-B2
View Details
Materials and methods for the synthesis of error-minimized nucleic acid molecules
US-11884916-B2
View DetailsMethods of cloning nucleic acids or producing proteins in a low endotoxin organism
US-11746321-B2
View DetailsProducts
Automated benchtop nucleic acid synthesis workstation
A benchtop platform that automates sequence-to-nucleic-acid workflows including synthesis, assembly, cloning, and amplification to accelerate construct generation.
On-site nucleic acid synthesis platform and kits for vaccine and therapeutic R&D
Platform concept and consumable kits to enable on-demand synthesis of DNA, RNA, and related constructs for vaccine scaffolds, antigen panels, diagnostic controls, and therapeutic research.
Automated benchtop nucleic acid synthesis workstation
A benchtop platform that automates sequence-to-nucleic-acid workflows including synthesis, assembly, cloning, and amplification to accelerate construct generation.
On-site nucleic acid synthesis platform and kits for vaccine and therapeutic R&D
Platform concept and consumable kits to enable on-demand synthesis of DNA, RNA, and related constructs for vaccine scaffolds, antigen panels, diagnostic controls, and therapeutic research.
Services
Laboratory services to assemble genomic constructs and produce high-diversity DNA libraries using automated benchtop synthesis and assembly platforms.
Provision of reagent kits and application support for on-instrument synthesis, assembly, and amplification workflows.
Laboratory services to assemble genomic constructs and produce high-diversity DNA libraries using automated benchtop synthesis and assembly platforms.
Provision of reagent kits and application support for on-instrument synthesis, assembly, and amplification workflows.
Expertise Areas
- Automated synthetic biology and on-demand nucleic acid production
- DNA and mRNA vaccine construct workflows
- High-throughput DNA library construction and screening
- Antibody and T-cell receptor (TCR) discovery support
Key Technologies
- Automated gene and mRNA synthesis workstations
- Isothermal enzymatic DNA assembly
- Cell-free DNA assembly and amplification
- mRNA synthesis workflows
News & Updates
Highlighting the BioXp® system's role in vaccine development and synthetic biology advancements.
Announcing advancements in the Digital-to-Biological Converter platform for on-demand vaccine printing.
Highlighting research on EZH2 and breast cancer using Gibson Assembly® cloning.
Introducing a cell-free DNA synthesis and amplification technology that accelerates gene and vaccine development.
Supporting rapid DNA and RNA synthesis for vaccine and therapeutic development against COVID-19.
Historical perspective on rapid DNA synthesis for vaccine development, including COVID-19.
Highlighting the BioXp® system's role in vaccine development and synthetic biology advancements.
Announcing advancements in the Digital-to-Biological Converter platform for on-demand vaccine printing.
Highlighting research on EZH2 and breast cancer using Gibson Assembly® cloning.
Introducing a cell-free DNA synthesis and amplification technology that accelerates gene and vaccine development.
Supporting rapid DNA and RNA synthesis for vaccine and therapeutic development against COVID-19.
Historical perspective on rapid DNA synthesis for vaccine development, including COVID-19.